Régnier G - Search Results

1

In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative.

Pierré A, Dunn TA, Kraus-Berthier L, Léonce S, Saint-Dizier D, Régnier G, Dhainaut A, Berlion M, Bizzari JP, Atassi G. Pierré A, et al. Among authors: regnier g. Invest New Drugs. 1992 Aug;10(3):137-48. doi: 10.1007/BF00877238. Invest New Drugs. 1992. PMID: 1428723

2

New triazine derivatives as potent modulators of multidrug resistance.

Dhainaut A, Régnier G, Atassi G, Pierré A, Léonce S, Kraus-Berthier L, Prost JF. Dhainaut A, et al. Among authors: regnier g. J Med Chem. 1992 Jun 26;35(13):2481-96. doi: 10.1021/jm00091a017. J Med Chem. 1992. PMID: 1352353

3

In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.

Cros S, Guilbaud N, Berlion M, Dunn T, Regnier G, Dhainaut A, Atassi G, Bizzari JP. Cros S, et al. Among authors: regnier g. Cancer Chemother Pharmacol. 1992;30(6):491-4. doi: 10.1007/BF00685604. Cancer Chemother Pharmacol. 1992. PMID: 1394807

4

New purines and purine analogs as modulators of multidrug resistance.

Dhainaut A, Regnier G, Tizot A, Pierre A, Leonce S, Guilbaud N, Kraus-Berthier L, Atassi G. Dhainaut A, et al. Among authors: regnier g. J Med Chem. 1996 Sep 27;39(20):4099-108. doi: 10.1021/jm960361i. J Med Chem. 1996. PMID: 8831775

5

S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.

Breugnot C, Privat S, Guillonneau C, Regnier G, Bouzom F, Vilaine JP, Lenaers A. Breugnot C, et al. Among authors: regnier g. J Pharmacol Exp Ther. 1994 May;269(2):515-20. J Pharmacol Exp Ther. 1994. PMID: 8182520

6

Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activity.

Duhault J, Boulanger M, Lonchampt M, Tisserand F, Holstorp S, Saint-Romas G, Pennel L, Regnier G. Duhault J, et al. Among authors: regnier g. Arzneimittelforschung. 1987 Dec;37(12):1353-62. Arzneimittelforschung. 1987. PMID: 2835053

7

Protective effect of S12340 on cardiac cells exposed to oxidative stress.

Iliou JP, Thollon C, Robin F, Cambarrat C, Guillonneau C, Régnier G, Lenaers A, Vilaine JP. Iliou JP, et al. Among authors: regnier g. Eur J Pharmacol. 1993 Oct 1;248(3):263-72. doi: 10.1016/0926-6917(93)90053-s. Eur J Pharmacol. 1993. PMID: 8293791

8

Triphenylpropylpiperazine derivatives as new potent analgetic substances.

Regnier GL, Canevari RJ, Le Douarec JC, Holstorp S, Daussy J. Regnier GL, et al. J Med Chem. 1972 Mar;15(3):295-301. doi: 10.1021/jm00273a600. J Med Chem. 1972. PMID: 5059214 No abstract available.

9

Bronchodilator substances. Part II: experimental study of a new antiasthmatic drug, S 1688, without beta-stimulant properties.

Duhault JL, Tisserand FP, Regnier GL. Duhault JL, et al. Among authors: regnier gl. Arzneimittelforschung. 1974 Dec;24(12):1970-4. Arzneimittelforschung. 1974. PMID: 4480359 No abstract available.

10

[Pharmacological studies of a new antitussive, 1-phenethyl-4-hydroxy-salicylamido-4-methyl-piperidine-hydrochloride (S 1592) (author's transl)].

Duhault J, Tisserand F, Regnier G. Duhault J, et al. Among authors: regnier g. Arzneimittelforschung. 1976 Apr;26(4):516-23. Arzneimittelforschung. 1976. PMID: 989005 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters